Evidence map›Paper›PMID 41007325›Full record

ArticleBiology2025

Synthesis, Characterization, and Screening Anticancer-Antibiofilm Activities of Theophylline Derivatives Containing CF

Serpil Demir Düşünceli, Kübra Açıkalın Coşkun, Murat Kaloğlu, Elvan Üstün, Reyhan Çalışkan, Yusuf Tutar

Abstract read
In one paragraph

Article in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Serpil Demir DüşünceliDepartment of Chemistry, Faculty of Science and Arts, Inönü University, 44280 Malatya, Türkiye.
Kübra Açıkalın CoşkunDepartment of Basic Medical Sciences, Division of Biology, Faculty of Medicine, Istanbul Aydın University, 34295 Istanbul, Türkiye.ORCID 0000-0002-0047-8368
Murat KaloğluDepartment of Chemistry, Faculty of Science and Arts, Inönü University, 44280 Malatya, Türkiye.ORCID 0000-0002-2770-5532
Elvan ÜstünDepartment of Chemistry, Faculty of Science and Art, Ordu University, 52200 Ordu, Türkiye.ORCID 0000-0002-0587-7261
Reyhan ÇalışkanDepartment of Medical Microbiology, Faculty of Medicine, Samsun University, 55030 Samsun, Türkiye.ORCID 0000-0002-2764-1823
Yusuf TutarDepartment of Basic Medical Sciences, Division of Biochemistry, Faculty of Medicine, Recep Tayyip Erdoğan University, 53350 Rize, Türkiye.ORCID 0000-0003-2613-9644

Funding

Recep Tayyip Erdoğan University Development Foundation 0202400802XX
6 · The paper itself

Abstract

backgroundTheophylline, which is biologically important and found in tea, coffee, and cocoa beans, can be synthesized chemically or by direct extraction and concentration from natural sources. Theophylline derivatives have garnered attention in recent years for their potential therapeutic effects on

methodsIn this study, a series of new theophylline derivatives containing substituted trifluoromethyl and trifluoromethoxy groups were synthesized. The structures of these new compounds were confirmed by NMR, FT-IR, and elemental analyses. Additionally, the anticancer activities of the molecules were analyzed against VEGFR-2, CYP P450, and estrogen receptor by molecular docking method. Furthermore, in vitro biological effects of the compounds were comprehensively evaluated in cancer (A549 and HeLa) and normal (BEAS-2B) cells. Cell viability was assessed by MTT assay, and selectivity index (SI) values were calculated to determine tumor-specific toxicity.

resultsN(7)-substituted theophyllines were prepared by the reaction of 1,3-dimethyl-3,7-dihydro-1

conclusionsThe synthesized molecules may provide insight into the development of potential therapeutic agents to the increasing antimicrobial resistance and biofilm-forming capacity of microorganisms. Additionally, compound 2-CF

Indexed as

antibiofilmanticancer activityantimicrobialmolecular dockingsubstituted theophylline

Identifiers

PMID41007325
PMCPMC12467740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.